Andrew Hill Selected Research

Integrase Inhibitors

12/2021	The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir disoproxil fumarate/emtricitabine/efavirenz.
2/2021	Are New Antiretroviral Treatments Increasing the Risk of Weight Gain?
1/2021	Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy: Republication.
1/2021	Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy.
1/2019	Are new antiretroviral treatments increasing the risks of clinical obesity?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Hill Research Topics

Disease

20	COVID-19 03/2022 - 04/2020
15	Infections 01/2022 - 01/2005
14	Hepatitis C 07/2021 - 08/2011
12	Obesity 12/2021 - 01/2019
10	Melanoma (Melanoma, Malignant) 10/2022 - 10/2011
9	Neoplasms (Cancer) 12/2020 - 08/2010
8	Disease Progression 03/2022 - 03/2007
7	Weight Gain 12/2021 - 10/2020
7	Acquired Immunodeficiency Syndrome (AIDS) 04/2019 - 04/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2011
6	Aneurysm (Aneurysms) 10/2021 - 10/2007
6	HIV Infections (HIV Infection) 01/2019 - 01/2004
5	Pain (Aches) 05/2022 - 01/2018
5	Body Weight (Weight, Body) 01/2022 - 04/2012
5	Pneumococcal Infections 01/2021 - 01/2016
4	Postoperative Pain 05/2022 - 01/2016
4	Neural Tube Defects (Exencephaly) 01/2021 - 01/2018
4	Tuberculosis (Tuberculoses) 01/2021 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 10/2018 - 10/2013
4	Coinfection 01/2018 - 11/2005
3	Myocardial Infarction 01/2022 - 01/2016
3	Weight Loss (Weight Reduction) 12/2021 - 01/2019
3	Fatigue 11/2021 - 10/2011
3	Inflammation (Inflammations) 01/2021 - 10/2018
3	Colitis 11/2020 - 11/2018
3	Human Influenza (Influenza) 05/2020 - 03/2016
3	Neutropenia 11/2018 - 01/2004
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2017 - 03/2005
3	Endoleak 02/2017 - 10/2007
3	Aortic Aneurysm (Aneurysm, Aortic) 02/2016 - 03/2011
3	Viremia 11/2014 - 04/2012
2	Stroke (Strokes) 01/2022 - 09/2012
2	Fever (Fevers) 01/2022 - 10/2011
2	Sepsis (Septicemia) 09/2021 - 11/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2019
2	Clinical Deterioration 01/2021 - 01/2017
2	Wounds and Injuries (Trauma) 01/2021 - 01/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 11/2020 - 10/2017
2	Pneumonia (Pneumonitis) 11/2020 - 01/2020
2	Drug-Related Side Effects and Adverse Reactions 11/2020 - 10/2020
2	Exanthema (Rash) 10/2020 - 01/2014
2	Necrosis 11/2018 - 08/2008
2	Abdominal Aortic Aneurysm 10/2018 - 05/2018
2	Microsatellite Instability 10/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

11	dolutegravirIBA 12/2021 - 01/2018
10	NivolumabIBA 10/2022 - 07/2015
10	Antiviral Agents (Antivirals)IBA 11/2020 - 04/2007
9	IpilimumabIBA 10/2022 - 07/2015
9	SofosbuvirIBA 01/2022 - 01/2016
9	daclatasvirIBA 01/2022 - 01/2016
9	RNA (Ribonucleic Acid)IBA 10/2020 - 03/2007
8	Pharmaceutical PreparationsIBA 03/2022 - 01/2009
8	tenofovir alafenamideIBA 12/2021 - 01/2019
7	NucleosidesIBA 02/2021 - 03/2005
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2006
6	Ivermectin (Mectizan)FDA Link 02/2022 - 08/2021
6	VaccinesIBA 01/2022 - 01/2016
6	LipidsIBA 01/2021 - 01/2014
5	Integrase InhibitorsIBA 12/2021 - 01/2019
5	Ritonavir (Norvir)FDA Link 01/2021 - 11/2005
5	Protease Inhibitors (Protease Inhibitor)IBA 07/2015 - 05/2010
4	efavirenz (Sustiva)FDA Link 12/2021 - 07/2015
4	Tenofovir (Viread)FDA Link 12/2021 - 10/2018
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2015
4	AntigensIBA 09/2019 - 09/2015
3	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 05/2022 - 07/2021
3	Poloxamer (Poloxamer 407)IBA 05/2022 - 01/2018
3	Emtricitabine (Emtriva)FDA Link 12/2021 - 10/2018
3	RacivirIBA 12/2021 - 10/2018
3	Reverse Transcriptase InhibitorsIBA 01/2021 - 03/2005
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2021 - 08/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2019
3	Ribavirin (Virazole)FDA LinkGeneric 11/2020 - 11/2014
3	Stavudine (Zerit)FDA LinkGeneric 01/2019 - 01/2004
3	etravirine (TMC-125)FDA Link 07/2015 - 03/2007
3	Darunavir (Prezista)FDA Link 04/2012 - 01/2009
2	Opioid Analgesics (Opioids)IBA 05/2022 - 12/2020
2	KetorolacIBA 05/2022 - 07/2021
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2021 - 03/2005
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 01/2018
2	nitazoxanide (NTZ)FDA Link 01/2021 - 05/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2017
2	Lopinavir FDA Link 01/2021 - 01/2009
2	Polysaccharides (Glycans)IBA 01/2021 - 09/2019
2	Raltegravir Potassium FDA Link 01/2021 - 04/2012
2	LigandsIBA 12/2020 - 07/2015
2	CreatinineIBA 10/2020 - 10/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 08/2013
2	C-Reactive ProteinIBA 01/2019 - 10/2018

Therapy/Procedure

30	Therapeutics 03/2022 - 01/2004
7	Drug Therapy (Chemotherapy) 01/2017 - 08/2010
5	Stents 09/2021 - 10/2008
5	Art Therapy 10/2020 - 02/2015
4	Length of Stay 01/2022 - 10/2018
4	Endovascular Aneurysm Repair 10/2021 - 10/2007
4	Bariatric Surgery 01/2020 - 01/2017
4	Highly Active Antiretroviral Therapy (HAART) 04/2006 - 03/2005
3	Aftercare (After-Treatment) 01/2017 - 08/2004
2	Knee Replacement Arthroplasty (Total Knee Replacement) 05/2022 - 01/2018